May 7 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* REPORT FROM THE ANNUAL GENERAL MEETING OF IRLAB
THERAPEUTICS AB
* IRLAB THERAPEUTICS AB - DISPOSITION OF COMPANY'S RESULTS
PROPOSED BY BOARD WAS ADOPTED BY ANNUAL GENERAL MEETING
* IRLAB THERAPEUTICS - AMOUNT AVAILABLE TO AGM, TOTALING SEK
420,888,103, BE TRANSFERRED IN FULL,THAT NO DIVIDEND SHALL BE
PAID FOR PAST FINANCIAL YEAR
* IRLAB THERAPEUTICS - AGMRESOLVED TO DISCHARGE BOARD
MEMBERS,MANAGING DIRECTOR FROM LIABILITY FOR THEIR
ADMINISTRATION DURING FINANCIAL YEAR 2019
* IRLAB THERAPEUTICS AB - LARS ADLERSSON, CAROLA LEMNE, EVA
LINDGREN, GUNNAR OLSSON, REIN PIIR AND LENA TORLEGÅRD WERE
RE-ELECTED AS BOARD MEMBERS
* IRLAB THERAPEUTICS AB - GUNNAR OLSSON WAS ELECTED AS NEW
CHAIRMAN OF BOARD AND CAROLA LEMNE WAS RE-ELECTED AS DEPUTY
CHAIRMAN OF BOARD
* IRLAB THERAPEUTICS AB - FIRM OF AUDITORS ÖHRLINGS
PRICEWATERHOUSECOOPERS AB WAS ELECTED AS AUDITOR OF COMPANY WITH
JOHAN RIPPE AS PRINCIPAL AUDITOR
Source text for Eikon: ID:nWkr11Dl9t
Further company coverage: IRLABa.ST
((Reuters.Briefs@thomsonreuters.com;))